Published in Vaccine Weekly, December 16th, 1996
The finding, reported by University of Southern California researcher Angeline Douvas and colleagues, could be of great importance in the development of an HIV vaccine.
"The current findings provide further evidence that individuals unexposed to HIV-1 may develop immunologic resistance by alternative mechanisms, possibly including molecular mimicry or exposure to as-yet-unidentified retroviruses," Douvas et al. wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.